No, the problem has been that the variant vaccines have not shown superior responses to variants vs. the original spike isolate in preclinical and small trials.
Incorrect, the beta variant vaccine for example showed quite good strength at stopping the beta variant vs. the wild type vaccine (which beta much more easily evaded). The problem is beta variant grew for a bit last year but is entirely gone now.